CD2 MicroBeads were developed for the positive selection or depletion of CD2+ cells from human PBMCs.
Related products for CD2 MicroBeads, human
PBMCs were labeled with CD2 MicroBeads. For positive selection, the cells were separated over an MS Column in a MiniMACS™ Separator. For depletion, the CD2+ cells were separated over an LD Column in a MidiMACS™ Separator.
CD2 MicroBeads were developed for the positive selection or depletion of CD2+ cells from human PBMCs.
CD2 is expressed on all T cells and most NK cells. The CD2 antigen is a 50 kDa single-chain transmembrane glycoprotein, also known as LFA-2 or receptor for sheep erythrocytes.
CD2 MicroBeads can be used for positive selection or depletion of CD2+ T and NK cells. They can also be used to deplete CD2+ cells from tonsils to isolate B cells.1,2
For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.
- Drenou, B. et al. (2004) Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas. Br J Haematol 127: 40-49
- Larousserie, F. et al. (2006) Differential effects of IL-27 on human B cell subsets. J Immunol 176: 5890-5897
You have previously chosen International as your location.
What do you want to do?